Kwality Pharmaceuticals
903.00
-18.75(-2.03%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-2.03%
1M+2.31%
6M-2.81%
1Y+0.39%
5Y+1,405.00%
View Company Insightsright
More news about Kwality Pharmaceuticals
26Jul 25
Kwality Pharmaceuticals Reshuffles Board, Appoints New Independent Director
Kwality Pharmaceuticals has appointed Dr. Vinod Kumar Sharma as an Additional Non-Executive Independent Director for a five-year term starting July 26, 2025, subject to shareholder approval. Dr. Sharma brings over 30 years of pharmaceutical industry experience. Kiran Kumar Verma has resigned as Independent Director effective July 26, 2025. The company has also restructured its Audit Committee and Nomination and Remuneration Committee following these changes.
19May 25
Kwality Pharmaceuticals Reports Q4 EBITDA Growth and Triple-Digit Profit Surge
Kwality Pharmaceuticals has announced impressive Q4 financial results. Net profit soared 222.22% year-over-year to ₹145.00 crore, while revenue increased by 25% to ₹115.00 crore. EBITDA grew to ₹25.90 crore, though the EBITDA margin slightly decreased to 22.38%. The company's performance indicates strong market positioning and effective operational management.
Kwality Pharmaceuticals
903.00
-18.75
(-2.03%)
1 Year Returns:+0.39%
Industry Peers
Influx Healthtech
230.55
(+4.99%)
Phaarmasia
72.48
(+5.00%)
Glen Industries
77.00
(-2.16%)
Unjha Formulations
24.71
(-0.68%)
Panchsheel Organics
137.00
(+0.66%)
Rajnish Wellness
0.68
(-4.23%)